Telehealth changed how a lot of people get a GLP-1. You fill out an intake, a clinician reviews it, and the prescription shows up at your door. Hims and Hers now runs the full branded lineup (Wegovy, Ozempic, Zepbound, Mounjaro) alongside compounded options, and the app throws in recipes, habit streaks, and sleep logging. More than a million people use it.
So here’s a fair question: if the app you already pay for does “tracking,” why add another one?
Short answer. Telehealth platforms are built to get you prescribed and refilled. They are good at that. They are not built to model what the drug is doing in your body week to week, and that’s the part that actually shapes how you feel.
Not medical advice. This article explains what different tools track and why. It doesn’t tell you which provider or medication to use. Talk to your prescriber about your treatment, and keep getting your prescription however works for you.
What telehealth logging is genuinely good at
Give credit where it’s due. A platform like Hims does several things well, and none of this is a knock on it:
- It writes and renews the prescription without a clinic trip.
- It keeps your orders and dose changes in one account.
- The lifestyle extras (recipe ideas, a habit nudge, a sleep log) are a reasonable on-ramp for someone who has never tracked anything before.
If that covers what you need, you’re set. Keep going. A lot of people, though, hit a wall about six weeks in, when the questions stop being “did I take it” and start being “why does week three of a dose feel different from week one.”
Where the built-in logging runs out
Basic in-app logging captures events. You took a dose. You slept seven hours. You ate a recipe. Useful, flat, and disconnected from the one thing driving your whole experience: the drug’s concentration in your blood, which rises and falls on a schedule.
Three gaps show up fast.
It doesn’t model your medication level between doses. Semaglutide has a half-life of about a week. Tirzepatide sits around five days. That means the drug is never at a steady amount. It peaks a couple of days after your injection and tapers before the next one. A habit tracker has no idea this curve exists. It can’t tell you that the hunger creeping back on day six is the taper, not a failure of willpower.
It scatters your side effects instead of connecting them. Nausea, fatigue, injection-site soreness, constipation. A lifestyle app might let you jot these in a note. What it won’t do is line them up against your dose timing and your medication curve, which is exactly the view a prescriber needs to decide whether to hold a dose, slow your titration, or push through.
It forgets. Switch platforms, cancel, or move from compounded to branded, and that history tends to evaporate. The record of how your body handled month two is worth keeping, and it shouldn’t be locked to whoever wrote this month’s script.
The curve is the whole point
Here’s the specific thing a dedicated tracker adds. It runs a pharmacokinetic model for your exact medication and dose, so you can see roughly where your drug level sits on any given day — climbing after an injection, near its peak, or tapering toward the next one.
Put your side effects and appetite on that same timeline and patterns you couldn’t feel suddenly read as obvious. The nausea that always lands the day after your shot. The “food noise” that goes quiet at peak and gets loud again late in the week. That’s the information that makes a titration conversation productive, and it’s the reason “know roughly when your next dose peaks” beats “you logged a dose” every time.
None of this competes with your telehealth prescription. It sits next to it. You get your medication from whoever you get it from, and you keep the clinical record of how it’s actually going.
Which tool does which job
| Job | Telehealth platform (Hims, etc.) | Dedicated GLP-1 tracker |
|---|---|---|
| Prescription and refills | Yes | No (stays with your provider) |
| Basic habit / sleep / recipe logging | Yes | Some |
| Modelled medication level between doses | No | Yes |
| Side effects tied to dose timing | No | Yes |
| Weight trend with projection | Limited | Yes |
| History that survives switching providers | Rarely | Yes |
| Peer community on the same medication | No | Yes |
The part telehealth can’t give you: people on the same drug
There’s one more thing a prescription app isn’t built to do, and it matters more than most feature lists admit. Picture week three of a dose. The nausea won’t quit, you’ve read the same forum thread twice, and what actually helps is hearing from someone who took this exact medication and came out the other side.
Traqr puts GLP-1 tracking and a moderated peer community in one app, so your doses, weight, and side effects sit next to people on the same medication. Topics map to the real journey: Wegovy, Mounjaro, compounded, side effects, food noise, plateaus. Every post runs through automated safety checks and human review, with report-and-block on everything. It’s peer support, not medical advice, and the disclaimer rides along in onboarding and the composer. Your private tracking stays separate from what you choose to share.
Compounded users, this is worth a specific note. If your source shifts (a pharmacy change, a move between compounded and branded), you want your history in a neutral place that isn’t tied to any one provider. We’re the place to land and keep the record. For the regulatory background on why compounded supply has been in flux, our 503A vs 503B explainer walks through what actually changed.
So, do you need both?
If you’re happy logging the basics and you never think about dose timing, the telehealth app is probably enough. If you’ve started asking why some weeks feel different, or you want a record that outlives your current provider, that’s the gap a dedicated tracker fills.
Keep your prescription where it is. Add the tracking layer that reads the curve. They do different jobs, and the second one is the difference between logging that you took a drug and understanding what it’s doing.
Traqr supports all eight major GLP-1 and anti-obesity medications, including compounded semaglutide. Nothing here is medical advice; talk to your prescriber about your treatment plan.